ChemoMetec Management
Management criteria checks 2/4
ChemoMetec's CEO is Martin Behrens, appointed in Dec 2023, has a tenure of 1.08 years. total yearly compensation is DKK2.92M, comprised of 30% salary and 70% bonuses, including company stock and options. directly owns 0.019% of the company’s shares, worth DKK1.70M. The average tenure of the management team and the board of directors is 1.1 years and 3.8 years respectively.
Key information
Martin Behrens
Chief executive officer
DKK 2.9m
Total compensation
| CEO salary percentage | 30.0% |
| CEO tenure | 1.1yrs |
| CEO ownership | 0.02% |
| Management average tenure | 1.1yrs |
| Board average tenure | 3.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | DKK 3m | DKK 877k | DKK 136m |
Compensation vs Market: Martin's total compensation ($USD402.52K) is below average for companies of similar size in the UK market ($USD2.30M).
Compensation vs Earnings: Insufficient data to compare Martin's compensation with company performance.
CEO
Martin Behrens (32 yo)
1.1yrs
Tenure
DKK 2,923,041
Compensation
Mr. Martin Helbo Behrens serves as CEO at ChemoMetec A/S since March 13, 2024. He is Chief Operating Officer of ChemoMetec A/S from December 2023. He was Vice Chief Operating Officer of ChemoMetec A/S from...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & COO | 1.1yrs | DKK 2.92m | 0.019% DKK 1.7m | |
| Chief Financial Officer | less than a year | no data | no data | |
| Chief Sales Officer | no data | no data | no data | |
| Chief Marketing & Strategy Officer | 1.1yrs | no data | no data | |
| Head of Marketing | 1.1yrs | no data | no data | |
| Head of R&D | no data | no data | no data | |
| Chief R&D Officer and Physicist & Project Manager | 1.1yrs | no data | no data |
1.1yrs
Average Tenure
Experienced Management: CHEMMC's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Deputy Chairman | no data | DKK 150.00k | 0.31% DKK 28.3m | |
| Independent Director | 10.3yrs | DKK 100.00k | 0.0083% DKK 756.7k | |
| Independent Director | 4.3yrs | DKK 100.00k | 0.00086% DKK 78.1k | |
| Chairman | 3.3yrs | DKK 360.00k | 0.011% DKK 1.0m | |
| Independent Director | 3.3yrs | DKK 100.00k | 0.0017% DKK 152.6k |
3.8yrs
Average Tenure
62yo
Average Age
Experienced Board: CHEMMC's board of directors are considered experienced (3.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/19 12:35 |
| End of Day Share Price | 2024/11/05 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ChemoMetec A/S is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kallum Titchmarsh | BofA Global Research |
| null null | Danske Bank |
| Simon Larsson | Danske Bank |